- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Trends in Value That Dr Daniel Mullins Expects to See in Coming Years
Daniel Mullins, PhD, discusses what trends he expects to see in coming years regarding value in healthcare.
Daniel Mullins, PhD, chair, Pharmaceutical Health Services Research, School oh Pharmacy, University of Maryland, discusses what trends he expects to see in coming years regarding value in healthcare.
Transcript
What are some trends you expect to see in coming years in regard to value in healthcare?
There are a couple of trends that I predict, some of which are perhaps futuristic and some of which really might happen in the next year. One trend that I hope we’ll see is that insurance companies will really include patients and the public in their coverage and decision-making bodies, like a pharmacy and therapeutics committee. Only when there’s a seat at the table for patients will we have the patient voice involved in coverage decisions. Another trend is the use of patient preferences in a really meaningful way that will really drive healthcare, and I think this is not just in real-world clinical settings, but I think what’s happening at the FDA now is really exciting and that too will drive the future of healthcare.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
